| Market Cap | 3.64B | P/E | 21.80 | EPS this Y | -21.00% | Ern Qtrly Grth | - |
| Income | 23.65M | Forward P/E | 12.67 | EPS next Y | 2.40% | 50D Avg Chg | 6.00% |
| Sales | 1.57B | PEG | 1.13 | EPS past 5Y | 3.81% | 200D Avg Chg | -13.00% |
| Dividend | N/A | Price/Book | 2.15 | EPS next 5Y | 6.30% | 52W High Chg | -27.00% |
| Recommedations | 3.20 | Quick Ratio | 1.75 | Shares Outstanding | 77.58M | 52W Low Chg | 19.00% |
| Insider Own | 3.19% | ROA | 3.51% | Shares Float | 66.44M | Beta | 1.10 |
| Inst Own | 95.12% | ROE | 1.47% | Shares Shorted/Prior | 4.57M/4.79M | Price | 44.48 |
| Gross Margin | 59.97% | Profit Margin | 1.51% | Avg. Volume | 817,158 | Target Price | 27.56 |
| Oper. Margin | 11.28% | Earnings Date | Oct 23 | Volume | 861,998 | Change | -1.05% |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
| Citigroup | Sell | Oct 1, 24 |
| BTIG | Sell | Aug 28, 24 |
| Citigroup | Sell | Aug 22, 24 |
| JMP Securities | Market Outperform | Jul 30, 24 |
| Truist Securities | Hold | Jul 30, 24 |
| Citigroup | Sell | Jul 30, 24 |
| BTIG | Sell | Jul 30, 24 |
| Truist Securities | Hold | Jul 16, 24 |
| Morgan Stanley | Underweight | Jul 15, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| McBreen Michael J. | EVP & President, CSS EVP & President, CSS | Mar 07 | Sell | 54.2943 | 1,843 | 100,064 | 28,796 | 03/08/23 |
| DAVIS ROBERT T. JR. | EVP & President, TT EVP & President, TT | Mar 01 | Sell | 55.21 | 1,566 | 86,459 | 45,920 | 03/03/23 |
| DAVIS ROBERT T. JR. | EVP & President, TT EVP & President, TT | Mar 01 | Option | 26.87 | 1,566 | 42,078 | 47,486 | 03/03/23 |
| Mosebrook Jeffrey | SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer | Dec 08 | Sell | 56.2162 | 279 | 15,684 | 8,552 | 12/08/22 |
| Evoli Lisa | Executive Vice Presi.. Executive Vice President &CHRO | Aug 10 | Sell | 55.8108 | 1,165 | 65,020 | 17,997 | 08/11/22 |
| Murphy Raymond G. | Director Director | Aug 05 | Sell | 55.7833 | 8,000 | 446,266 | 40,825 | 08/08/22 |
| Mosebrook Jeffrey | SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer | Aug 02 | Sell | 56.775 | 437 | 24,811 | 8,831 | 08/03/22 |
| Evoli Lisa | Executive Vice Presi.. Executive Vice President &CHRO | Jun 15 | Sell | 55.93 | 900 | 50,337 | 19,911 | 06/16/22 |
| Tru St Partnership, L.P. | 10% Owner 10% Owner | Dec 16 | Sell | 64.92 | 300,000 | 19,476,000 | 8,515,930 | 03/25/22 |
| McBreen Michael J. | EVP & President, CSS EVP & President, CSS | Mar 03 | Sell | 69 | 2,205 | 152,145 | 17,233 | 03/03/21 |
| Arduini Peter J | President & CEO President & CEO | Dec 21 | Option | 15.79 | 45,000 | 710,550 | 261,713 | 12/21/20 |
| Arduini Peter J | President & CEO President & CEO | Dec 21 | Sell | 61.97 | 45,000 | 2,788,650 | 216,713 | 12/21/20 |
| Coleman Glenn | Executive Vice Presi.. Executive Vice President & COO | Nov 12 | Sell | 55.14 | 9,400 | 518,316 | 36,494 | 11/12/20 |